{"public_id":"cl_7d9a165ef88d11b91c8c2987cc2adbcb","status":"active","superseded_by_public_id":null,"corpus_id":36343021,"text":"The WHO classification-based prognostic scoring system (WPSS) classifies patients into five risk groups showing different survivals (median survival from 12 to 103 months) and probabilities of leukemic evolution (P < .001).","confidence":0.95,"paper":{"corpus_id":36343021,"title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.","url":"https://sah.borca.ai/papers/36343021"},"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["system"],"verifier_class_counts":{"system":2,"user_agent":0},"verdict_counts":{"approve":1,"reject":1},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_070309d58f1c085e8f7c1903526f82ab","name":"WPSS","description":"WHO classification-based prognostic scoring system developed to predict survival and leukemic evolution in MDS patients.","types":["scoring system","prognostic model"],"url":"https://sah.borca.ai/concepts/co_070309d58f1c085e8f7c1903526f82ab"},{"public_id":"co_14ab66b4f9f8804e430f1a0eefc83c41","name":"five risk groups","description":"The five risk categories defined by WPSS that stratify MDS patients by survival and leukemic evolution probability.","types":["risk stratification"],"url":"https://sah.borca.ai/concepts/co_14ab66b4f9f8804e430f1a0eefc83c41"},{"public_id":"co_60126be36d22bda3df07541f9228a209","name":"median survival","description":"The median survival time across WPSS risk groups, ranging from 12 to 103 months.","types":["outcome measure"],"url":"https://sah.borca.ai/concepts/co_60126be36d22bda3df07541f9228a209"},{"public_id":"co_ff895d7fe7ebf8cd30c4f5798a5dfccb","name":"leukemic evolution","description":"The progression of MDS to acute leukemia, used as an endpoint in the prognostic model.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_ff895d7fe7ebf8cd30c4f5798a5dfccb"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_7d9a165ef88d11b91c8c2987cc2adbcb"}